SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-002080
Filing Date
2023-01-10
Accepted
2023-01-10 17:12:52
Documents
11
Period of Report
2023-02-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0123_gamidacellltd.htm DEF 14A 790786
2 GRAPHIC tformula_001.jpg GRAPHIC 15437
3 GRAPHIC tformula_002.jpg GRAPHIC 20108
4 GRAPHIC tformula_003.jpg GRAPHIC 21617
5 GRAPHIC tformula_004.jpg GRAPHIC 23557
6 GRAPHIC tformula_005.jpg GRAPHIC 17710
7 GRAPHIC tformula_006.jpg GRAPHIC 29503
8 GRAPHIC tgamida_logo.jpg GRAPHIC 61177
9 GRAPHIC tproxy_001.jpg GRAPHIC 996303
10 GRAPHIC tproxy_002.jpg GRAPHIC 1102049
11 GRAPHIC trobert_sign.jpg GRAPHIC 13196
  Complete submission text file 0001213900-23-002080.txt   3962359
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38716 | Film No.: 23521845
SIC: 2836 Biological Products, (No Diagnostic Substances)